Chonnam Med J.
2006 Aug;42(2):79-84.
Clincal Analysis of the Effectiveness of the Terlipressin Combined with Endoscopic Variceal Ligation in Acute Esophageal Variceal Bleeding
- Affiliations
-
- 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. choisk@chonnam.ac.kr
Abstract
- Terlipressin is widely used in acute variceal bleeding to reduce the bleeding. It acts by constricting mesenteric arteries, thus reducing portal venous flow and portal pressure. This study was tried to assess the efficacy and safety of terlipressin combined with endoscopic variceal ligation (EVL) in acute esophageal variceal bleeding and to evaluate clinical risk factors related to rebleeding. 43 patients with acute esophageal variceal bleeding received terlipressin (2 mg i.v. initially and 1 mg i.v. every 4 hours for 3 days) combined with EVL. Initial hemostasis rate was 98% (42/43 cases). 5-day and 42-day cumulative rebleeding rates were 12% (5/43 cases) and 28% (12/43 cases). The rebleeding sites were other esophageal varix (58%), EVL-induced ulcer (33%) and combined gastric varix (8%). The mortality rate within 6 week was 14%. The clinical factor related to rebleeding was poor liver function (Child-Pugh class C). Terlipressin combined with EVL is effective and safe in the treatment of acute esophageal variceal bleeding.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparison of the effects and complications of combined therapies using endoscopic variceal ligation with octreotide or terlipressin in the control of acute esophageal variceal bleeding
- The Use of Vasoconstrictors in Acute Variceal Bleeding: How Long Is Enough?
- Removal of a Trigger Cord Stuck between Bands during Endoscopic Multiple-Band Ligation for Treating Esophageal Variceal Hemorrhage
- Endoscopic Treatment and Prevention of Acute Variceal Hemorrhage
- Comparison of Endoscopic Variceal Ligation versus Combined Ligation and Sclerotherapy for Bleeding Esophageal Varices
